NCT02375633View on ClinicalTrials.gov

Phase 3 Study of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

November 30, 2014

Conditions
Chronic Back Pain
Interventions
DRUG

DW-330SR2

DRUG

Pelubiprofen

Sponsors
All Listed Sponsors
lead

Daewon Pharmaceutical Co., Ltd.

INDUSTRY

NCT02375633 - Phase 3 Study of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients | Biotech Hunter | Biotech Hunter